Active Funding Opportunities and Notices for NICHD
NICHD publishes and participates in various notices of funding opportunities (NOFOs) and NIH Guide Notices (NOTs) to support research and training activities.
NOTs and Active NOFOs for NICHD
Please note: the following are sorted by date, from most recent to older. Select a table heading to change how to sort the information.
| Number | Exp. Date | Activity Code(s) | Title |
|---|---|---|---|
| RFA-MH-23-110 | August 12, 2025 | F32 | BRAIN Initiative Fellows: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32) |
| NOT-HD-23-008 | January 1, 2028 | R03,R21,U24,U54,R01 | Notice of Early Expiration of NOT-HD-22-043 "Notice of Special Interest ( NOSI ): Implementation Science to Advance Maternal Health and Maternal Health Equity for the IMPROVE initiative" |
| PAR-22-265 | May 26, 2025 | T32 | Jointly Sponsored Ruth L. Kirschstein National Research Service Award Institutional Predoctoral Training Program in the Neurosciences (T32 Clinical Trial Not Allowed) |
| PAR-23-128 | May 3, 2025 | X01 | Biological Testing Facility (X01 Clinical Trial Not Allowed) |
| RFA-NS-24-005 | January 21, 2026 | U01 | BRAIN Initiative: Optimization of Instrumentation and Device Technologies for Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed) |
| RFA-NS-24-004 | January 21, 2026 | R01 | BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed) |
| PAR-23-117 | August 5, 2025 | P30 | Developmental Centers for AIDS Research (P30 Clinical Trial Not Allowed) |
| PAR-23-116 | August 5, 2025 | P30 | Centers for AIDS Research (P30 Clinical Trial Not Allowed) |
| PAR-23-120 | May 16, 2025 | X01 | Diagnostic Centers of Excellence (X01 Clinical Trial Not Allowed) |
| PAR-23-131 | May 8, 2026 | R21 | Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional) |
| PAR-23-130 | May 8, 2026 | R01 | Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional) |
| NOT-HD-23-005 | April 1, 2026 | 333 | Notice of Special Interest (NOSI): Administrative Supplements to Leverage Network Infrastructure to Advance Multisite Research for Women, Children, Pregnant and Lactating Individuals and/or Persons with Disabilities |
| NOT-NR-23-008 | January 1, 2027 | Request for Information (RFI): Future Directions in Violence Against Women Research | |
| NOT-NS-23-035 | January 1, 2028 | Notice of Intent to Publish a Funding Opportunity Announcement for BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed) | |
| NOT-NS-23-036 | January 1, 2028 | Notice of Intent to Publish a Funding Opportunity Announcement for BRAIN Initiative: Optimization of Instrumentation and Device Technologies for Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed) | |
| NOT-NS-23-037 | January 1, 2028 | Notice of Early Expiration of NINDS BRAIN Initiative Funding Opportunity Announcements (FOA) RFA-NS-21-026 and RFA-NS-21-027 | |
| NOT-HD-23-002 | January 1, 2028 | Notice announcing Webinar and Frequently Asked Questions (FAQs) for PAR-23-037 NICHD Multisite Clinical Research: Leveraging Network Infrastructure to Advance Research for Women, Children, Pregnant and Lactating Individuals, and Persons with Disabilities | |
| NOT-HD-23-004 | January 1, 2028 | Notice of Clarification for the Research Scope in RFA-HD-24-002 "Development of Novel Nonsteroidal Contraceptive Methods (R61/R33 - Clinical Trial Not Allowed)" | |
| PAR-23-112 | January 8, 2026 | R01 | Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 - Clinical Trial Optional) |
| PAR-23-074 | January 8, 2026 | R01 | In-Depth Phenotyping and Research Using IMPC-Generated Knockout Mouse Strains Exhibiting Embryonic or Perinatal Lethality or Subviability (R01 Clinical Trial Not Allowed) |
BACK TO TOP